Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Advancements in diagnostic technologies
3.2.1.2 Growth in assisted reproductive technologies
3.2.1.3 Increasing research and development in fertility treatments
3.2.1.4 Rising awareness and education
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of treatment
3.2.2.2 Side effects & complications
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.5.1 Core technologies
3.5.2 Adjacent technologies
3.6 Pricing analysis, 2023
3.7 Future market trends
3.8 Porter’s analysis
3.9 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Test
5.2.1 DNA fragmentation technique
5.2.2 Oxidative stress analysis
5.2.3 Microscopic examination
5.2.4 Sperm agglutination
5.2.5 Computer assisted semen analysis
5.2.6 Sperm penetration assay
5.2.7 Other tests
5.3 Treatment
5.3.1 Medication
5.3.2 ART & varicocele surgery reagents & kits
Chapter 6 Market Estimates and Forecast, By Distribution Channel, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Hospitals pharmacies
6.3 Retail pharmacies and drug stores
6.4 Online pharmacies
Chapter 7 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 France
7.3.4 Spain
7.3.5 Italy
7.3.6 Netherlands
7.3.7 Rest of Europe
7.4 Asia Pacific
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Australia
7.4.5 South Korea
7.4.6 Rest of Asia Pacific
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.5.3 Argentina
7.5.4 Rest of Latin America
7.6 Middle East and Africa
7.6.1 South Africa
7.6.2 Saudi Arabia
7.6.3 UAE
7.6.4 Rest of Middle East and Africa
Chapter 8 Company Profiles
8.1 Andrology Solutions
8.2 ASKA Pharmaceutical Co., Ltd.
8.3 AdvaCare Pharma
8.4 Bayer AG
8.5 CinnaGen Co.
8.6 CaerusBiotech
8.7 Endo International plc
8.8 HalotechDNA
8.9 Intas Pharmaceuticals Ltd.
8.10 Merck KGaA
8.11 Sanofi
8.12 SCSA Diagnostics, Inc
8.13 The Cooper Companies, Inc.
8.14 Vitrolife Group
8.15 Zydus Lifesciences Limited
